AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
Comparison of the QTDT analysis for IgE in the CSGA data set
Authors: Page, GP Wilcox, MA Occhiuto, J Adak, S Neuberg, D Bajorunaite, R George, V
Citation: Gp. Page et al., Comparison of the QTDT analysis for IgE in the CSGA data set, GENET EPID, 21, 2001, pp. S312-S316
Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593 - A phase III trial of the Eastern Cooperative Oncology Group
Authors: Schiller, JH Adak, S Cella, D DeVore, RF Johnson, DH
Citation: Jh. Schiller et al., Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593 - A phase III trial of the Eastern Cooperative Oncology Group, J CL ONCOL, 19(8), 2001, pp. 2114-2122
Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: A laboratory ancillary study on an Eastern Cooperative Oncology Group prospective randomized trial of postoperative adjuvant therapy
Authors: Schiller, JH Adak, S Feins, RH Keller, SM Fry, WA Livingston, RB Hammond, MEM Wolf, B Sabatini, L Jett, J Kohman, L Johnson, DH
Citation: Jh. Schiller et al., Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: A laboratory ancillary study on an Eastern Cooperative Oncology Group prospective randomized trial of postoperative adjuvant therapy, J CL ONCOL, 19(2), 2001, pp. 448-457
Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck
Authors: Colevas, AD Read, R Thornhill, J Adak, S Tishler, R Busse, P Li, Y Posner, M
Citation: Ad. Colevas et al., Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck, INT J RAD O, 51(3), 2001, pp. 599-604
Quality of life assessment in advanced non-small-cell lung cancer patientsundergoing an accelerated radiotherapy regimen: Report of ECOG study 4593
Authors: Auchter, RM Scholtens, D Adak, S Wagner, H Cella, DF Mehta, MP
Citation: Rm. Auchter et al., Quality of life assessment in advanced non-small-cell lung cancer patientsundergoing an accelerated radiotherapy regimen: Report of ECOG study 4593, INT J RAD O, 50(5), 2001, pp. 1199-1206
An essential role of active site arginine residue in iodide binding and histidine residue in electron transfer for iodide oxidation by horseradish peroxidase
Authors: Adak, S Bandyopadhyay, D Bandyopadhyay, U Banerjee, RK
Citation: S. Adak et al., An essential role of active site arginine residue in iodide binding and histidine residue in electron transfer for iodide oxidation by horseradish peroxidase, MOL C BIOCH, 218(1-2), 2001, pp. 1-11
A proximal tryptophan in NO synthase controls activity by a novel mechanism
Authors: Adak, S Stuehr, DJ
Citation: S. Adak et Dj. Stuehr, A proximal tryptophan in NO synthase controls activity by a novel mechanism, J INORG BIO, 83(4), 2001, pp. 301-308
Survival analysis with time-varying relative risks: A tree-based approach
Authors: Xu, R Adak, S
Citation: R. Xu et S. Adak, Survival analysis with time-varying relative risks: A tree-based approach, METH INF M, 40(2), 2001, pp. 141-147
Regulation of the properties of the heme-NO complexes in nitric-oxide synthase by hydrogen bonding to the proximal cysteine
Authors: Couture, M Adak, S Stuehr, DJ Rousseau, DL
Citation: M. Couture et al., Regulation of the properties of the heme-NO complexes in nitric-oxide synthase by hydrogen bonding to the proximal cysteine, J BIOL CHEM, 276(41), 2001, pp. 38280-38288
Chimeras of nitric-oxide synthase types I and III establish fundamental correlates between heme reduction, heme-NO complex formation, and catalytic activity
Authors: Adak, S Aulak, KS Stuehr, DJ
Citation: S. Adak et al., Chimeras of nitric-oxide synthase types I and III establish fundamental correlates between heme reduction, heme-NO complex formation, and catalytic activity, J BIOL CHEM, 276(26), 2001, pp. 23246-23252
A kinetic simulation model that describes catalysis and regulation in nitric-oxide synthase
Authors: Santolini, J Adak, S Curran, CML Stuehr, DJ
Citation: J. Santolini et al., A kinetic simulation model that describes catalysis and regulation in nitric-oxide synthase, J BIOL CHEM, 276(2), 2001, pp. 1233-1243
Neuronal nitric-oxide synthase mutant (Ser-1412 -> Asp) demonstrates surprising connections between heme reduction, NO complex formation, and catalysis
Authors: Adak, S Santolini, J Tikunova, S Wang, Q Johnson, JD Stuehr, DJ
Citation: S. Adak et al., Neuronal nitric-oxide synthase mutant (Ser-1412 -> Asp) demonstrates surprising connections between heme reduction, NO complex formation, and catalysis, J BIOL CHEM, 276(2), 2001, pp. 1244-1252
A Phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck
Authors: Colevas, AD Amrein, PC Gomolin, H Barton, JJ Read, RR Adak, S Benner, S Costello, R Posner, MR
Citation: Ad. Colevas et al., A Phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck, CANCER, 92(2), 2001, pp. 326-331
A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck
Authors: Colevas, AD Adak, S Amrein, PC Barton, JJ Costello, R Posner, MR
Citation: Ad. Colevas et al., A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck, ANN ONCOL, 11(5), 2000, pp. 535-539
A phase II study of gemcitabine and 5-fluorouracil in metastatic pancreatic cancer: An Eastern Cooperative Oncology Group Study (E3296)
Authors: Berlin, JD Adak, S Vaughn, DJ Flinker, D Blaszkowsky, L Harris, JE Benson, AB
Citation: Jd. Berlin et al., A phase II study of gemcitabine and 5-fluorouracil in metastatic pancreatic cancer: An Eastern Cooperative Oncology Group Study (E3296), ONCOL-BASEL, 58(3), 2000, pp. 215-218
A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer.
Authors: Keller, SM Adak, S Wagner, H Herskovic, A Komaki, R Brooks, BJ Perry, MC Livingston, RB Johnson, DH
Citation: Sm. Keller et al., A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer., N ENG J MED, 343(17), 2000, pp. 1217-1222
Arginine conversion to nitroxide by tetrahydrobiopterin-free neuronal nitric-oxide synthase - Implications for mechanism
Authors: Adak, S Wang, Q Stuehr, DJ
Citation: S. Adak et al., Arginine conversion to nitroxide by tetrahydrobiopterin-free neuronal nitric-oxide synthase - Implications for mechanism, J BIOL CHEM, 275(43), 2000, pp. 33554-33561
Molecular basis for hyperactivity in tryptophan 409 mutants of neuronal NOsynthase
Authors: Adak, S Wang, Q Stuehr, DJ
Citation: S. Adak et al., Molecular basis for hyperactivity in tryptophan 409 mutants of neuronal NOsynthase, J BIOL CHEM, 275(23), 2000, pp. 17434-17439
Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer
Authors: Keller, SM Adak, S Wagner, H Johnson, DH
Citation: Sm. Keller et al., Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer, ANN THORAC, 70(2), 2000, pp. 358-365
Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck
Authors: Colevas, AD Norris, CM Tishler, RB Fried, MP Gomolin, HI Amrein, P Nixon, A Lamb, C Costello, R Barton, J Read, R Adak, S Posner, MR
Citation: Ad. Colevas et al., Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck, J CL ONCOL, 17(11), 1999, pp. 3503-3511
Tryptophan 409 controls the activity of neuronal nitric-oxide synthase by regulating nitric oxide feedback inhibition
Authors: Adak, S Crooks, C Wang, Q Crane, BR Tainer, JA Getzoff, ED Stuehr, DJ
Citation: S. Adak et al., Tryptophan 409 controls the activity of neuronal nitric-oxide synthase by regulating nitric oxide feedback inhibition, J BIOL CHEM, 274(38), 1999, pp. 26907-26911
Mutational analysis of the tetrahydrobiopterin-binding site in inducible nitric-oxide synthase
Authors: Ghosh, S Wolan, D Adak, S Crane, BR Kwon, NS Tainer, JA Getzoff, ED Stuehr, DJ
Citation: S. Ghosh et al., Mutational analysis of the tetrahydrobiopterin-binding site in inducible nitric-oxide synthase, J BIOL CHEM, 274(34), 1999, pp. 24100-24112
Role of reductase domain cluster 1 acidic residues in neuronal nitric-oxide synthase - characterization of the FMN-free enzyme
Authors: Adak, S Ghosh, S Abu-Soud, HM Stuehr, DJ
Citation: S. Adak et al., Role of reductase domain cluster 1 acidic residues in neuronal nitric-oxide synthase - characterization of the FMN-free enzyme, J BIOL CHEM, 274(32), 1999, pp. 22313-22320
Time-dependent spectral analysis of nonstationary time series
Authors: Adak, S
Citation: S. Adak, Time-dependent spectral analysis of nonstationary time series, J AM STAT A, 93(444), 1998, pp. 1488-1501
Microstructure evolution and grain growth in the sintering of 3Y-TZP ceramics
Authors: Luo, J Adak, S Stevens, R
Citation: J. Luo et al., Microstructure evolution and grain growth in the sintering of 3Y-TZP ceramics, J MATER SCI, 33(22), 1998, pp. 5301-5309
Risultati: 1-25 | 26-26